Cancer clinical trials have been based on low accrual rates. Barriers to recruitment of
minority populations affect the generalizability and impact of trial findings for those …

Background Recruiting minorities and underserved populations into population‐based
studies is a long standing challenge. This study examined the feasibility of recruiting adults …

Despite decades of effort, lower income people and ethnic minorities continue to be
underrepresented as participants in health research. A group of racially and ethnically …

Evidence shows that minority patients are underrepresented in clinical trials. The
development of new drugs and treatments, however, requires that clinical research studies …

OBJECTIVES: To explore gender differences in perceptions of 1) barriers and motivators to
participation in clinical trials and perceived need of clinical trials and 2) perceptions of risks …

Minority underrepresentation exists in medical research including cardiovascular clinical
trials, but the hypothesis that this relates to distrust in medical researchers is unproven …

Research suggests that community involvement is integral to solving public health problems,
including involvement in clinical trials—a gold standard. Significant racial/ethnic disparities …

Racial/ethnic minority populations are under-represented in clinical trials and Hispanic
participation rates are particularly low. This study assessed barriers and facilitators to clinical …

Objectives. In accordance with the NIH Revitalization Act of 1993, the National Institutes of
Health and the Alcohol, Drug and Mental Health Administration require grant applicants and …

American Indians (AIs) have some of the poorest documented health outcomes of any
racial/ethnic group. Research plays a vital role in addressing these health disparities …